coronavirus vaccine candidate could include data from 5,000-10,000 participants, Reuters reported, citing Denis Logunov, a director at the Gamaleya Institute that developed the vaccine.
Russia plans to publish preliminary data about the Sputnik V jab as early as November.The Sputnik V trial, involving 40,000 volunteers, has been underway in Moscow since the beginning of September.Meanwhile, Moderna Inc Chief Executive Officer Stéphane Bancel expects interim results from its COVID-19 vaccine trial in November and that the U.S government could give an emergency use nod in December, the Wall Street Journal reported.Another vaccine-maker Pfizer, which is developing the vaccine with German partner BioNTech, has said it may confirm if the vaccine.